Pharmaceutical Executive Daily: Susan G. Komen Releases Breast Cancer Outlook for 2026
Feb 4, 2026
01:46
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
In today’s Pharmaceutical Executive Daily, Susan G. Komen releases its 2026 breast cancer progress outlook, industry leaders explore how pharma can tap into emerging talent hubs, and Novartis’ Q4 results highlight mounting pressure from its upcoming patent cliff.
Pharmaceutical Executive